Heron Patrick J

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$119.6M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Heron Patrick J

According to the SEC Form 4 filings, Heron Patrick J, being in a position of

  1. director at Arcutis Biotherapeutics, Inc.,
    оver the last 12 months, has bought 21052 shares for $199,994, and sold 0 shares,
    over all time since 2020-02-04, has bought 1271052 shares for $22.2M, and sold 0 shares.

The largest purchase of all time was on 2022-05-03 and amounted to 1764706 shares of HilleVax, Inc. for $30M.

Biography of Heron Patrick J

No biography is available at this moment.

2024-09-18PurchaseMirum Pharmaceuticals, Inc.
MIRM
director
115
0.0002%
$37.40$4,301+4.51%
2024-09-06PurchaseMirum Pharmaceuticals, Inc.
MIRM
director
230
0.0005%
$41.58$9,563-3.27%
2024-03-04PurchaseArcutis Biotherapeutics, Inc.
ARQT
director
21,052
0.019%
$9.50$199,994-12.42%
2023-09-13PurchaseMirum Pharmaceuticals, Inc.
MIRM
director
2,625
0.0068%
$31.02$81,425-4.37%
2023-09-12PurchaseMirum Pharmaceuticals, Inc.
MIRM
director
3,750
0.0096%
$30.60$114,764-7.76%
2023-09-11PurchaseMirum Pharmaceuticals, Inc.
MIRM
director
4,687
0.0122%
$30.30$142,027-5.85%
2023-08-31PurchaseMirum Pharmaceuticals, Inc.
MIRM
147,991
0.3838%
$26.25$3.88M+7.87%
2022-08-05PurchaseArcutis Biotherapeutics, Inc.
ARQT
250,000
0.3482%
$20.00$5M-38.17%
2022-05-03PurchaseHilleVax, Inc.
HLVX
1.76M
5.6072%
$17.00$30M-24.63%
2020-06-16PurchaseVaxcyte, Inc.
PCVX
director
500,000
2.06%
$16.00$8M-12.07%
2020-03-03PurchasePassage Bio, Inc.
PASG
1.1M
5.6173%
$18.00$19.8M-5.13%
2020-02-04PurchaseArcutis Biotherapeutics, Inc.
ARQT
1M
2.7334%
$17.00$17M+5.03%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
900,000
5.3814%
$15.00$13.5M+5.09%
2018-05-30PurchaseIterum Therapeutics plc
ITRM
director
912,198
13.7745%
$13.00$11.86M-40.58%
2015-05-12PurchaseCollegium Pharmaceutical, Inc.
COLL
300,000
2.3503%
$12.00$3.6M+44.38%
2015-04-20PurchaseCidara Therapeutics, Inc.
CDTX
director
400,000
3.8201%
$16.00$6.4M-6.34%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.